Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion type Assertion NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_head.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion description "[Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic myeloproliferative diseases (CMPDs) and in poor-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_provenance.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion evidence source_evidence_literature NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_provenance.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion SIO_000772 18587431 NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_provenance.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion wasDerivedFrom befree-2016 NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_provenance.
- NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_assertion wasGeneratedBy ECO_0000203 NP679255.RAyPFCMSc1S9L3qEdQaeLSZcFjr_luOfXarkZ_l5WfALI130_provenance.